Trial Details

TERMINATED
Basic Information
Clinical ID c1609
Identifier NCT03597971
Trial Title HMPL004-6599 Phase I Dose-escalating Study
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis|Crohn Disease
Interventions DRUG: HMPL004-6599|DRUG: Placebo
Participant Information
Sponsor Nutrition Science Partners Limited
City Perth
Country/Region Australia
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2018-03-20
Primary Completion Date 2018-11-19
Completion Date 2018-11-19